B. Ultsch

1.1k total citations
48 papers, 782 citations indexed

About

B. Ultsch is a scholar working on Epidemiology, Surgery and Health. According to data from OpenAlex, B. Ultsch has authored 48 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 9 papers in Surgery and 9 papers in Health. Recurrent topics in B. Ultsch's work include Influenza Virus Research Studies (9 papers), Herpesvirus Infections and Treatments (9 papers) and Vaccine Coverage and Hesitancy (9 papers). B. Ultsch is often cited by papers focused on Influenza Virus Research Studies (9 papers), Herpesvirus Infections and Treatments (9 papers) and Vaccine Coverage and Hesitancy (9 papers). B. Ultsch collaborates with scholars based in Germany, Netherlands and Belgium. B. Ultsch's co-authors include Ole Wichmann, Wolfgang Greiner, Oliver Damm, Anette Siedler, Gérard Krause, Thomas Reinhold, Thorsten Rieck, Stefan Scholz, Johannes Horn and Rafael Mikolajczyk and has published in prestigious journals such as Gut, BMC Public Health and Vaccine.

In The Last Decade

B. Ultsch

44 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Ultsch Germany 18 527 138 123 114 88 48 782
Angela Guo United States 11 717 1.4× 163 1.2× 199 1.6× 182 1.6× 33 0.4× 27 974
Eithne MacMahon United Kingdom 19 606 1.1× 104 0.8× 38 0.3× 89 0.8× 61 0.7× 42 1.1k
Yi Luo United States 18 770 1.5× 286 2.1× 130 1.1× 120 1.1× 49 0.6× 72 1.5k
Jon E. Stek United States 23 1.2k 2.2× 122 0.9× 286 2.3× 198 1.7× 25 0.3× 49 1.5k
Kenneth J. Bart United States 16 399 0.8× 187 1.4× 41 0.3× 12 0.1× 74 0.8× 27 691
Leszek Szenborn Poland 20 816 1.5× 136 1.0× 47 0.4× 16 0.1× 108 1.2× 125 1.3k
Lidia Oostvogels Belgium 21 733 1.4× 80 0.6× 225 1.8× 158 1.4× 13 0.1× 40 1.2k
Barbara Pahud United States 14 292 0.6× 133 1.0× 28 0.2× 35 0.3× 82 0.9× 36 616
Ian F. Cook Australia 14 249 0.5× 96 0.7× 18 0.1× 27 0.2× 223 2.5× 29 808
Steve Black United States 14 313 0.6× 129 0.9× 56 0.5× 7 0.1× 133 1.5× 27 749

Countries citing papers authored by B. Ultsch

Since Specialization
Citations

This map shows the geographic impact of B. Ultsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Ultsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Ultsch more than expected).

Fields of papers citing papers by B. Ultsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Ultsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Ultsch. The network helps show where B. Ultsch may publish in the future.

Co-authorship network of co-authors of B. Ultsch

This figure shows the co-authorship network connecting the top 25 collaborators of B. Ultsch. A scholar is included among the top collaborators of B. Ultsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Ultsch. B. Ultsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Buck, Philip O., Ekkehard Beck, Noam Y. Kirson, et al.. (2024). New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement. Vaccines. 12(3). 234–234. 2 indexed citations
3.
Joshi, Keya, Stefan Scholz, Michael Maschio, et al.. (2023). Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany. Journal of Medical Economics. 27(1). 39–50. 9 indexed citations
4.
Nautrup, B Poulsen, Ruprecht Schmidt‐Ott, Martin Eichner, et al.. (2022). Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany. Human Vaccines & Immunotherapeutics. 18(5). 2058304–2058304. 5 indexed citations
5.
Batram, Manuel, Julian Witte, Magdalena Schwarz, et al.. (2021). Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007–2018. Dermatology and Therapy. 11(3). 1009–1026. 33 indexed citations
6.
Scholz, Stefan, Magdalena Schwarz, Ekkehard Beck, et al.. (2021). Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease. Infectious Diseases and Therapy. 11(1). 367–387. 11 indexed citations
7.
Scholz, Stefan, et al.. (2020). Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany. Value in Health. 24(1). 32–40. 10 indexed citations
8.
Scholz, Stefan, et al.. (2018). PRM33 - HUMAN CAPITAL VS. FRICTION COST APPROACH – DIFFERENCES IN THE PRESENCE OF DEATH AND LONG-TERM CONSEQUENCES. Value in Health. 21. S361–S361. 4 indexed citations
9.
Remschmidt, Cornelius, et al.. (2017). Is the impact of childhood influenza vaccination less than expected: a transmission modelling study. BMC Infectious Diseases. 17(1). 258–258. 24 indexed citations
10.
Damm, Oliver, S. Scholz, B. Ultsch, et al.. (2016). A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness. Value in Health. 19(7). A419–A419. 4 indexed citations
11.
Christensen, Hannah, Judith Koch, Caroline Trotter, et al.. (2016). Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany. Vaccine. 34(29). 3412–3419. 35 indexed citations
12.
Horn, Johannes, André Karch, Oliver Damm, et al.. (2016). Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination. Human Vaccines & Immunotherapeutics. 12(7). 1–11. 23 indexed citations
13.
Ultsch, B., Oliver Damm, Matthias Perleth, & Ole Wichmann. (2015). Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany. Value in Health. 18(7). A569–A569. 2 indexed citations
14.
Ultsch, B., Oliver Damm, Philippe Beutels, et al.. (2015). Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. 34(3). 227–244. 95 indexed citations
15.
Damm, Oliver, B. Ultsch, Johannes Horn, et al.. (2015). Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 15(1). 533–533. 34 indexed citations
16.
Kuhlmann, Alexander, Marina Treskova, B. Ultsch, et al.. (2015). Cost-Effectiveness of Pneumococcal Vaccination of Elderly In Germany. Value in Health. 18(7). A584–A584. 3 indexed citations
17.
Aidelsburger, Pamela, Katharina Böhm, Jürgen Wasem, et al.. (2014). Cost-effectiveness of childhood rotavirus vaccination in Germany. Vaccine. 32(17). 1964–1974. 20 indexed citations
18.
Aidelsburger, Pamela, Katja Boehm, Jürgen Wasem, et al.. (2013). Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany. Value in Health. 16(7). A351–A351. 4 indexed citations
19.
Reimann, H. J., U. Schmidt, B. Ultsch, Timothy J. Sullivan, & P. Wendt. (1984). Action of FPL 52694 on gastric acid secretion in the healthy human stomach.. Gut. 25(11). 1221–1224. 1 indexed citations
20.
Schmidt, U., et al.. (1984). [The effect pf antacids on the tissue histamine and prostaglandin (PGE2) content of the gastric mucosa].. PubMed. 102(25-26). 697–700. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Guo Breakdown of academic impact, for papers by Eithne MacMahon Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by Jon E. Stek Breakdown of academic impact, for papers by Kenneth J. Bart Breakdown of academic impact, for papers by Leszek Szenborn Breakdown of academic impact, for papers by Lidia Oostvogels Breakdown of academic impact, for papers by Barbara Pahud Breakdown of academic impact, for papers by Ian F. Cook Breakdown of academic impact, for papers by Steve Black
Rankless by CCL
2026